首页 > 最新文献

Pneumologie最新文献

英文 中文
[Statement paper on the implementation of a national organized program in Germany for the early detection of lung cancer in risk populations using low-dose CT screening including management of screening findings]. [关于在德国实施国家组织的使用低剂量CT筛查早期检测风险人群肺癌癌症的计划的声明文件,包括筛查结果的管理]。
IF 1.2 Q4 RESPIRATORY SYSTEM Pub Date : 2024-01-01 Epub Date: 2023-10-10 DOI: 10.1055/a-2175-4580
Torsten Gerriet Blum, Jens Vogel-Claussen, Stefan Andreas, Torsten T Bauer, Jörg Barkhausen, Volker Harth, Hans-Ulrich Kauczor, Wulf Pankow, Katrin Welcker, Rudolf Kaaks, Hans Hoffmann

The process of implementing early detection of lung cancer with low-dose CT (LDCT) in Germany has gained significant momentum in recent years. It is expected that the ordinance of the Federal Ministry for the Environment, Nature Conservation, Nuclear Safety and Consumer Protection (BMUV) on early detection of lung cancer, which has been commented on by the professional societies, will come into effect by the end of 2023. Based on this regulation, the Federal Joint Committee (G-BA) will set up a program for early lung cancer detection with LDCT in the near future. In this position paper, the specialist societies involved in lung cancer screening present concrete cornerstones for a uniform, structured and quality-assured early detection program for lung cancer in Germany to make a constructive contribution to this process.

近年来,德国实施低剂量CT(LDCT)早期检测癌症的进程取得了显著进展。预计联邦环境、自然保护、核安全和消费者保护部(BMUV)关于癌症早期检测的法令将于2023年底生效,该法令已得到专业协会的评论。根据这项规定,联邦联合委员会(G-BA)将在不久的将来制定LDCT早期检测癌症的计划。在这份立场文件中,参与癌症筛查的专家协会为德国癌症肺癌统一、结构化和质量保证的早期检测计划提供了具体的基石,以对这一过程做出建设性贡献。
{"title":"[Statement paper on the implementation of a national organized program in Germany for the early detection of lung cancer in risk populations using low-dose CT screening including management of screening findings].","authors":"Torsten Gerriet Blum, Jens Vogel-Claussen, Stefan Andreas, Torsten T Bauer, Jörg Barkhausen, Volker Harth, Hans-Ulrich Kauczor, Wulf Pankow, Katrin Welcker, Rudolf Kaaks, Hans Hoffmann","doi":"10.1055/a-2175-4580","DOIUrl":"10.1055/a-2175-4580","url":null,"abstract":"<p><p>The process of implementing early detection of lung cancer with low-dose CT (LDCT) in Germany has gained significant momentum in recent years. It is expected that the ordinance of the Federal Ministry for the Environment, Nature Conservation, Nuclear Safety and Consumer Protection (BMUV) on early detection of lung cancer, which has been commented on by the professional societies, will come into effect by the end of 2023. Based on this regulation, the Federal Joint Committee (G-BA) will set up a program for early lung cancer detection with LDCT in the near future. In this position paper, the specialist societies involved in lung cancer screening present concrete cornerstones for a uniform, structured and quality-assured early detection program for lung cancer in Germany to make a constructive contribution to this process.</p>","PeriodicalId":20197,"journal":{"name":"Pneumologie","volume":" ","pages":"15-34"},"PeriodicalIF":1.2,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41209957","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Horse allergy: Curly Horses can mediate immune tolerance. 马过敏:卷曲的马可以介导免疫耐受。
IF 1.2 Q4 RESPIRATORY SYSTEM Pub Date : 2024-01-01 Epub Date: 2023-10-12 DOI: 10.1055/a-2101-9533
Alexandra Mitlehner, Caspar Mitlehner, Monika Reißmann, Peter Stoll, Ines Swoboda, Wolfgang Mitlehner

American Bashkir Curly Horses are claimed to be hypoallergenic, but this has not been clinically proven. In the present study, the effect of exposure to Curly Horses was investigated in 141 patients allergic to horses by measuring their lung function and nasal patency during Curly Horse contact. Continuous contact with Curly Horses, including riding and brushing, decreased the allergic riders' reactivity as measured by FEV1, PEF, and PNIF. Subsequent visits (up to 40 or more hours of riding) further reduced reactivity to the Curly Horses. Allergic events to horses occurred only in 72 out of 1312 riding hours, mainly in the first ten riding hours.In 41 out of the 141 patients, it was further investigated whether repeated exposure to Curly Horses could induce tolerance to other horses. Patients in the tolerance induction study were tested annually for horse allergy using a nasal provocation test. The tolerance induction study showed that exposure to Curly Horses induced immune tolerance to other horses in 88% of patients who completed the study.To understand the mechanism causing hypoallergenicity, we performed IgE immunoblots to determine whether Curly Horse hairs contain IgE binding proteins. However, no differences in IgE reactivity were found between Curly and non-Curly Horses. Moreover, the immune tolerance induction study patients did not show decreased IgE reactivity to hairs from Curly or non-Curly Horses even though patients had developed tolerance. However, we did find increasing levels of anti-horse IgG antibodies in the study patients.Overall, our data strongly suggests that continuous exposure to Curly Horses can induce immune tolerance, rendering these patients non-reactive to horses. The reason for the reduced clinical allergenicity of Curly Horses remains unclear, but the data suggest that blocking IgG antibodies may be of importance for immune tolerance development.

美国巴什基尔冰壶马被认为是低致敏性的,但这还没有得到临床证实。在本研究中,通过测量141名对马过敏的患者在接触卷曲马期间的肺功能和鼻腔通畅性,研究了接触卷曲马的影响。通过FEV1、PEF和PNIF测量,与卷曲马的持续接触,包括骑行和刷牙,降低了过敏骑手的反应性。随后的访问(长达40小时或更长时间的骑行)进一步降低了对卷曲马的反应。在1312个骑行小时中,只有72个小时发生对马的过敏事件,主要发生在前10个骑行小时。在141名患者中的41名患者中,进一步研究了反复接触卷曲马是否会诱导对其他马的耐受性。耐受性诱导研究中的患者每年都会使用鼻腔激发试验对马过敏进行测试。耐受性诱导研究表明,88%的完成研究的患者暴露于卷曲马会诱导对其他马的免疫耐受。为了了解引起低致敏性的机制,我们进行了IgE免疫印迹,以确定卷曲的马毛是否含有IgE结合蛋白。然而,在卷曲马和非卷曲马之间没有发现IgE反应性的差异。此外,免疫耐受诱导研究患者对卷曲马或非卷曲马的毛发的IgE反应性没有降低,尽管患者已经产生了耐受性。然而,我们确实发现研究患者的抗马IgG抗体水平在增加。总的来说,我们的数据有力地表明,持续接触卷曲马可以诱导免疫耐受,使这些患者对马没有反应。卷曲马临床致敏性降低的原因尚不清楚,但数据表明,阻断IgG抗体可能对免疫耐受的发展至关重要。
{"title":"Horse allergy: Curly Horses can mediate immune tolerance.","authors":"Alexandra Mitlehner, Caspar Mitlehner, Monika Reißmann, Peter Stoll, Ines Swoboda, Wolfgang Mitlehner","doi":"10.1055/a-2101-9533","DOIUrl":"10.1055/a-2101-9533","url":null,"abstract":"<p><p>American Bashkir Curly Horses are claimed to be hypoallergenic, but this has not been clinically proven. In the present study, the effect of exposure to Curly Horses was investigated in 141 patients allergic to horses by measuring their lung function and nasal patency during Curly Horse contact. Continuous contact with Curly Horses, including riding and brushing, decreased the allergic riders' reactivity as measured by FEV<sub>1</sub>, PEF, and PNIF. Subsequent visits (up to 40 or more hours of riding) further reduced reactivity to the Curly Horses. Allergic events to horses occurred only in 72 out of 1312 riding hours, mainly in the first ten riding hours.In 41 out of the 141 patients, it was further investigated whether repeated exposure to Curly Horses could induce tolerance to other horses. Patients in the tolerance induction study were tested annually for horse allergy using a nasal provocation test. The tolerance induction study showed that exposure to Curly Horses induced immune tolerance to other horses in 88% of patients who completed the study.To understand the mechanism causing hypoallergenicity, we performed IgE immunoblots to determine whether Curly Horse hairs contain IgE binding proteins. However, no differences in IgE reactivity were found between Curly and non-Curly Horses. Moreover, the immune tolerance induction study patients did not show decreased IgE reactivity to hairs from Curly or non-Curly Horses even though patients had developed tolerance. However, we did find increasing levels of anti-horse IgG antibodies in the study patients.Overall, our data strongly suggests that continuous exposure to Curly Horses can induce immune tolerance, rendering these patients non-reactive to horses. The reason for the reduced clinical allergenicity of Curly Horses remains unclear, but the data suggest that blocking IgG antibodies may be of importance for immune tolerance development.</p>","PeriodicalId":20197,"journal":{"name":"Pneumologie","volume":" ","pages":"47-57"},"PeriodicalIF":1.2,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41209959","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
E-cigarette use-associated lung injury (EVALI). 电子烟使用相关肺损伤(EVALI)。
IF 1.2 Q4 RESPIRATORY SYSTEM Pub Date : 2024-01-01 Epub Date: 2023-10-19 DOI: 10.1055/a-2161-0105
Nathaly Yessenia Tituana, Claudia Gabriela Clavijo, Evelyn Fernanda Espinoza, Viviana Alexandra Tituana

The prevalence of vaping has overtaken conventional cigarettes as the most frequent form of nicotine consumption among 15-24-year olds. There are currently a large number of both legitimate and illegitimate products and suppliers offering more than 8000 different flavors of vape on the market, whose additives are not tested, studied or regulated and whose safety and toxicity profile remains unknown. In vitro studies have demonstrated a dose-dependent decrease in the viability of normal human bronchial epithelial cells after exposure to vapor from electronic vape devices.Short- and medium-term studies to date indicate that vapor-induced pulmonary lesions are the most serious and commonly reported side effect; such lesions include bilateral ground glass opacities in lung bases with subpleural preservation, bilateral infiltrates, pleural effusion, pneumomediastinum and nodular opacities. Cases of EVALI have been described in patients with daily exposure, as well as in users who reported having been exposed to these substances at least once a month. The most frequently inhaled substances are THC, flavored liquids of unknown content, and nicotine.The clinical manifestations of dyspnea and cough are the most frequent respiratory symptomatology, in addition to constitutional manifestations such as fever and chills, and gastrointestinal manifestations such as vomiting, nausea, abdominal pain and diarrhea. To these can be added the presence of tachypnea, tachycardia, elevated blood pressure, hypoxia, leukocytosis with neutrophilia and elevated ESR.

电子烟的流行率已经超过传统香烟,成为15-24岁人群中最常见的尼古丁消费形式。目前,市场上有大量合法和非法的产品和供应商提供8000多种不同口味的电子烟,其添加剂没有经过测试、研究或监管,其安全性和毒性状况仍然未知。体外研究表明,暴露于电子烟设备的蒸汽后,正常人支气管上皮细胞的生存能力呈剂量依赖性降低。迄今为止的短期和中期研究表明,蒸汽诱导的肺部病变是最严重和最常见的副作用;此类病变包括胸膜下保留的双侧肺基底磨玻璃样阴影、双侧浸润、胸腔积液、纵隔气肿和结节性阴影。EVALI的病例描述为每天接触的患者,以及报告每月至少接触一次这些物质的使用者。最常被吸入的物质是四氢大麻酚、含量未知的调味液体和尼古丁。呼吸困难和咳嗽的临床表现是最常见的呼吸道症状,此外还有发烧和发冷等体质表现,以及呕吐、恶心、腹痛和腹泻等胃肠道表现。除此之外,还可能出现呼吸急促、心动过速、血压升高、缺氧、白细胞增多伴中性粒细胞增多和ESR升高。
{"title":"E-cigarette use-associated lung injury (EVALI).","authors":"Nathaly Yessenia Tituana, Claudia Gabriela Clavijo, Evelyn Fernanda Espinoza, Viviana Alexandra Tituana","doi":"10.1055/a-2161-0105","DOIUrl":"10.1055/a-2161-0105","url":null,"abstract":"<p><p>The prevalence of vaping has overtaken conventional cigarettes as the most frequent form of nicotine consumption among 15-24-year olds. There are currently a large number of both legitimate and illegitimate products and suppliers offering more than 8000 different flavors of vape on the market, whose additives are not tested, studied or regulated and whose safety and toxicity profile remains unknown. In vitro studies have demonstrated a dose-dependent decrease in the viability of normal human bronchial epithelial cells after exposure to vapor from electronic vape devices.Short- and medium-term studies to date indicate that vapor-induced pulmonary lesions are the most serious and commonly reported side effect; such lesions include bilateral ground glass opacities in lung bases with subpleural preservation, bilateral infiltrates, pleural effusion, pneumomediastinum and nodular opacities. Cases of EVALI have been described in patients with daily exposure, as well as in users who reported having been exposed to these substances at least once a month. The most frequently inhaled substances are THC, flavored liquids of unknown content, and nicotine.The clinical manifestations of dyspnea and cough are the most frequent respiratory symptomatology, in addition to constitutional manifestations such as fever and chills, and gastrointestinal manifestations such as vomiting, nausea, abdominal pain and diarrhea. To these can be added the presence of tachypnea, tachycardia, elevated blood pressure, hypoxia, leukocytosis with neutrophilia and elevated ESR.</p>","PeriodicalId":20197,"journal":{"name":"Pneumologie","volume":" ","pages":"58-69"},"PeriodicalIF":1.2,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10791482/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49681341","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Treatment of MDR, pre-XDR, XDR and rifampicin resistant tuberculosis or in case of intolerance to at least rifampicin in Austria, Germany and Switzerland - Amendment dated 19.09.2023 to the Sk2-Guideline: Tuberculosis in adulthood of the German Central Committee against Tuberculosis (DZK) on behalf of the German Respiratory Society (DGP)]. 【在奥地利、德国和瑞士治疗耐多药、广泛耐药前、广泛耐药和利福平耐药性结核病,或在至少对利福平不耐受的情况下——德国中央结核病防治委员会(DZK)代表德国呼吸学会(DGP)于2023年9月19日修订的Sk2指南:成年期结核病】。
IF 1.2 Q4 RESPIRATORY SYSTEM Pub Date : 2024-01-01 Epub Date: 2023-11-06 DOI: 10.1055/a-2182-1609
Ralf Otto-Knapp, Torsten Bauer, Folke Brinkmann, Cornelia Feiterna-Sperling, Inna Friesen, Hilte Geerdes-Fenge, Pia Hartmann, Brit Häcker, Barbara Hauer, Walter Haas, Jan Heyckendorf, Martin Kuhns, Christoph Lange, Florian P Maurer, Albert Nienhaus, Martin Priwitzer, Elvira Richter, Helmut J F Salzer, Otto Schoch, Nicolas Schönfeld, Tom Schaberg

In December 2022, based on the assessment of new evidence, the World Health Organization (WHO) updated its guidelines for the treatment of drug-resistant tuberculosis (TB). The evaluation of both, these recommendations, and the latest study data, makes it necessary to update the existing guidelines on the treatment of at least rifampicin-resistant tuberculosis for the German-speaking region, hereby replacing the respective chapters. A shortened MDR-TB treatment of at least 6 month using the fixed and non-modifiable drug combination of bedaquiline, pretomanid, linezolid, and moxifloxacin (BPaLM) is now also recommended for Germany, Austria, and Switzerland under certain conditions. This recommendation applies to TB cases with proven rifampicin resistance, including rifampicin monoresistance. For treatment of pre-extensively drug resistant TB (pre-XDR-TB), an individualized treatment for 18 months adjusted to resistance data continues to be the primary recommendation. The non-modifiable drug combination of bedaquiline, pretomanid, and linezolid (BPaL) may be used alternatively in pre-XDR TB if all prerequisites are met. The necessary prerequisites for the use of BPaLM and BPaL are presented in this amendment to the S2k guideline for 'Tuberculosis in adulthood'.

2022年12月,根据对新证据的评估,世界卫生组织(世界卫生组织)更新了其耐药结核病治疗指南。对这两项建议和最新研究数据的评估表明,有必要更新德语地区至少治疗利福平耐药性结核病的现有指南,从而取代各自的章节。在某些条件下,德国、奥地利和瑞士也建议使用贝达奎林、普托曼、利奈唑胺和莫西沙星(BPaLM)的固定和不可改变的药物组合,将耐多药结核病治疗缩短至少6个月。本建议适用于已证实对利福平有耐药性的结核病病例,包括对利福平单耐药性。对于广泛耐药前结核病(广泛耐药前结核)的治疗,根据耐药性数据调整18个月的个体化治疗仍然是主要建议。如果满足所有先决条件,贝达奎林、普瑞托曼和利奈唑胺(BPaL)的不可改变药物组合可替代用于广泛耐药前结核病。使用BPaLM和BPaL的必要先决条件在S2k“成年期结核病”指南的修订中提出。
{"title":"[Treatment of MDR, pre-XDR, XDR and rifampicin resistant tuberculosis or in case of intolerance to at least rifampicin in Austria, Germany and Switzerland - Amendment dated 19.09.2023 to the Sk2-Guideline: Tuberculosis in adulthood of the German Central Committee against Tuberculosis (DZK) on behalf of the German Respiratory Society (DGP)].","authors":"Ralf Otto-Knapp, Torsten Bauer, Folke Brinkmann, Cornelia Feiterna-Sperling, Inna Friesen, Hilte Geerdes-Fenge, Pia Hartmann, Brit Häcker, Barbara Hauer, Walter Haas, Jan Heyckendorf, Martin Kuhns, Christoph Lange, Florian P Maurer, Albert Nienhaus, Martin Priwitzer, Elvira Richter, Helmut J F Salzer, Otto Schoch, Nicolas Schönfeld, Tom Schaberg","doi":"10.1055/a-2182-1609","DOIUrl":"10.1055/a-2182-1609","url":null,"abstract":"<p><p>In December 2022, based on the assessment of new evidence, the World Health Organization (WHO) updated its guidelines for the treatment of drug-resistant tuberculosis (TB). The evaluation of both, these recommendations, and the latest study data, makes it necessary to update the existing guidelines on the treatment of at least rifampicin-resistant tuberculosis for the German-speaking region, hereby replacing the respective chapters. A shortened MDR-TB treatment of at least 6 month using the fixed and non-modifiable drug combination of bedaquiline, pretomanid, linezolid, and moxifloxacin (BPaLM) is now also recommended for Germany, Austria, and Switzerland under certain conditions. This recommendation applies to TB cases with proven rifampicin resistance, including rifampicin monoresistance. For treatment of pre-extensively drug resistant TB (pre-XDR-TB), an individualized treatment for 18 months adjusted to resistance data continues to be the primary recommendation. The non-modifiable drug combination of bedaquiline, pretomanid, and linezolid (BPaL) may be used alternatively in pre-XDR TB if all prerequisites are met. The necessary prerequisites for the use of BPaLM and BPaL are presented in this amendment to the S2k guideline for 'Tuberculosis in adulthood'.</p>","PeriodicalId":20197,"journal":{"name":"Pneumologie","volume":" ","pages":"35-46"},"PeriodicalIF":1.2,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71485114","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hinweise auf die Rolle von Autoantikörpern für den IPF-Progress 自身抗体在 IPF 进展过程中发挥作用的证据
IF 1.2 Q4 RESPIRATORY SYSTEM Pub Date : 2023-12-01 DOI: 10.1055/a-2111-0727
{"title":"Hinweise auf die Rolle von Autoantikörpern für den IPF-Progress","authors":"","doi":"10.1055/a-2111-0727","DOIUrl":"https://doi.org/10.1055/a-2111-0727","url":null,"abstract":"","PeriodicalId":20197,"journal":{"name":"Pneumologie","volume":"122 1","pages":""},"PeriodicalIF":1.2,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138986446","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Early detection of lung cancer - current status and implementation scenarios]. [肺癌早期检测--现状和实施方案]。
IF 1.2 Q4 RESPIRATORY SYSTEM Pub Date : 2023-12-01 Epub Date: 2023-12-13 DOI: 10.1055/a-1531-0131
Rudolf M Huber

The prognosis of conventionally diagnosed lung cancer patients is still rather poor. Two large, randomized trials using screening by low dose CT could demonstrate that early detection in persons with smoking as risk factor can improve this prognosis. Early detection of lung cancer can be achieved by structured screening programs using low dose CT for persons at increased risk, but in addition also by consequent management of incidental pulmonary nodules, which are seen on imaging for other reasons. Integral part of these programs should be prevention measures, especially a consequent, repeated, low-threshold offer of a service for smoking cessation. Programs for lung cancer screening for persons at increased risk are only beneficial for the screenees and cost-effective, if the various parts of the program are optimally integrated and coordinated and all necessary disciplines (especially respiratory medicine, radiology, pathology, thoracic surgery, radiotherapy) are included in a multidisciplinary manner. For Germany the certified lung cancer centres in structured cooperation with physicians in private practice (respiratory physicians, radiologists, general practitioners) would be a good option. It is essential that there is a good perception for the need of early detection of lung cancer in politics and the public and that the persons at risk are reached, contacted and motivated by various methods.

传统诊断的肺癌患者预后仍然很差。两项利用低剂量 CT 进行筛查的大型随机试验表明,对吸烟作为危险因素的患者进行早期检测可以改善预后。肺癌的早期发现可以通过对高危人群使用低剂量 CT 进行有计划的筛查来实现,此外,还可以通过对因其他原因在影像学检查中发现的偶然肺结节进行相应的处理来实现。这些计划的组成部分应该是预防措施,尤其是随之而来的、反复的、低门槛的戒烟服务。对高危人群进行肺癌筛查的计划,只有在计划的各个部分得到最佳整合和协调,并且所有必要的学科(尤其是呼吸内科、放射科、病理科、胸外科、放疗科)都以多学科的方式参与其中时,才能使被筛查者受益,并且具有成本效益。在德国,认证的肺癌中心与私人诊所的医生(呼吸科医生、放射科医生、全科医生)进行有组织的合作将是一个很好的选择。至关重要的是,政界和公众对早期发现肺癌的必要性有良好的认识,并通过各种方法接触、联系和激励高危人群。
{"title":"[Early detection of lung cancer - current status and implementation scenarios].","authors":"Rudolf M Huber","doi":"10.1055/a-1531-0131","DOIUrl":"https://doi.org/10.1055/a-1531-0131","url":null,"abstract":"<p><p>The prognosis of conventionally diagnosed lung cancer patients is still rather poor. Two large, randomized trials using screening by low dose CT could demonstrate that early detection in persons with smoking as risk factor can improve this prognosis. Early detection of lung cancer can be achieved by structured screening programs using low dose CT for persons at increased risk, but in addition also by consequent management of incidental pulmonary nodules, which are seen on imaging for other reasons. Integral part of these programs should be prevention measures, especially a consequent, repeated, low-threshold offer of a service for smoking cessation. Programs for lung cancer screening for persons at increased risk are only beneficial for the screenees and cost-effective, if the various parts of the program are optimally integrated and coordinated and all necessary disciplines (especially respiratory medicine, radiology, pathology, thoracic surgery, radiotherapy) are included in a multidisciplinary manner. For Germany the certified lung cancer centres in structured cooperation with physicians in private practice (respiratory physicians, radiologists, general practitioners) would be a good option. It is essential that there is a good perception for the need of early detection of lung cancer in politics and the public and that the persons at risk are reached, contacted and motivated by various methods.</p>","PeriodicalId":20197,"journal":{"name":"Pneumologie","volume":"77 12","pages":"1016-1026"},"PeriodicalIF":1.2,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138808877","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
COVID-19: Algorithmus zur Risikoprognose während der Omicron-Welle COVID-19: 欧米克隆波期间的风险预测算法
IF 1.2 Q4 RESPIRATORY SYSTEM Pub Date : 2023-12-01 DOI: 10.1055/a-2204-5227
{"title":"COVID-19: Algorithmus zur Risikoprognose während der Omicron-Welle","authors":"","doi":"10.1055/a-2204-5227","DOIUrl":"https://doi.org/10.1055/a-2204-5227","url":null,"abstract":"","PeriodicalId":20197,"journal":{"name":"Pneumologie","volume":"5 2","pages":""},"PeriodicalIF":1.2,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139015964","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cystische Fibrose (CF): Dreifachtherapie verbessert Monozytenfunktion 囊性纤维化(CF):三联疗法可改善单核细胞功能
IF 1.2 Q4 RESPIRATORY SYSTEM Pub Date : 2023-12-01 DOI: 10.1055/a-2110-2231
{"title":"Cystische Fibrose (CF): Dreifachtherapie verbessert Monozytenfunktion","authors":"","doi":"10.1055/a-2110-2231","DOIUrl":"https://doi.org/10.1055/a-2110-2231","url":null,"abstract":"","PeriodicalId":20197,"journal":{"name":"Pneumologie","volume":"88 ","pages":""},"PeriodicalIF":1.2,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138988731","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Tuberculosis Infection Control & Hygiene - Recommendations of the DZK]. [结核病感染控制和卫生-DZK的建议]。
IF 1.2 Q4 RESPIRATORY SYSTEM Pub Date : 2023-12-01 Epub Date: 2023-10-13 DOI: 10.1055/a-2172-9575
Peter Witte, Mardjan Arvand, Stefanie Barth, Roland Diel, Inna Friesen, Petra Gastmeier, Brit Häcker, Barbara Hauer, Martin Kuhns, Albert Nienhaus, Ralf Otto-Knapp, Elvira Richter, Nicoletta Wischnewski, Renate Ziegler, Torsten Bauer

Preventing the spread of the disease is an essential goal in the care and treatment of tuberculosis. In addition to early diagnosis and effective therapies, isolation of infectious patients and adequate hygiene measures are of particular importance for infection prevention. The present recommendations replace the previous recommendations "tuberculosis infection control" from 2012 and take into account the current national and international recommendations and as well as new scientific findings. After a description of the infection and the transmission pathways, the necessary prevention and hygiene measures in health care facilities are comprehensively presented. Since the last revision of the recommendations on infection prevention, international recommendations and the KRINKO recommendation on ending isolation have been changed. In accordance with this, under certain conditions in the case of sensitive tuberculosis, de-isolation in health care facilities can take place after 14 days without taking the sputum findings into account. The second part of the recommendations explains in detail the measures to be taken in special situations and areas, such as general practitioners, ambulance services and care facilities. Here, the recommendations on respiratory protection have been simplified; for staff, an FFP2 mask is now generally considered sufficient.

预防这种疾病的传播是结核病护理和治疗的一个重要目标。除了早期诊断和有效治疗外,隔离感染患者和采取适当的卫生措施对预防感染尤为重要。本建议取代了2012年“结核病感染控制”的先前建议,并考虑到了当前的国家和国际建议以及新的科学发现。在描述了感染和传播途径后,全面介绍了卫生保健设施中必要的预防和卫生措施。自上次修订感染预防建议以来,国际建议和KRINKO关于结束隔离的建议都发生了变化。根据这一点,在某些情况下,在敏感结核病的情况下,可以在14天后在卫生保健机构解除隔离,而不考虑痰液检查结果。建议的第二部分详细解释了在特殊情况和领域应采取的措施,如全科医生、救护车服务和护理设施。在这里,关于呼吸保护的建议已经简化;对于工作人员来说,现在一般认为一个FFP2口罩就足够了。
{"title":"[Tuberculosis Infection Control & Hygiene - Recommendations of the DZK].","authors":"Peter Witte, Mardjan Arvand, Stefanie Barth, Roland Diel, Inna Friesen, Petra Gastmeier, Brit Häcker, Barbara Hauer, Martin Kuhns, Albert Nienhaus, Ralf Otto-Knapp, Elvira Richter, Nicoletta Wischnewski, Renate Ziegler, Torsten Bauer","doi":"10.1055/a-2172-9575","DOIUrl":"10.1055/a-2172-9575","url":null,"abstract":"<p><p>Preventing the spread of the disease is an essential goal in the care and treatment of tuberculosis. In addition to early diagnosis and effective therapies, isolation of infectious patients and adequate hygiene measures are of particular importance for infection prevention. The present recommendations replace the previous recommendations \"tuberculosis infection control\" from 2012 and take into account the current national and international recommendations and as well as new scientific findings. After a description of the infection and the transmission pathways, the necessary prevention and hygiene measures in health care facilities are comprehensively presented. Since the last revision of the recommendations on infection prevention, international recommendations and the KRINKO recommendation on ending isolation have been changed. In accordance with this, under certain conditions in the case of sensitive tuberculosis, de-isolation in health care facilities can take place after 14 days without taking the sputum findings into account. The second part of the recommendations explains in detail the measures to be taken in special situations and areas, such as general practitioners, ambulance services and care facilities. Here, the recommendations on respiratory protection have been simplified; for staff, an FFP2 mask is now generally considered sufficient.</p>","PeriodicalId":20197,"journal":{"name":"Pneumologie","volume":" ","pages":"983-1000"},"PeriodicalIF":1.2,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41209958","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
In Gedenken an Dr. med. Robert Kropp 17. November 1931 – 10. September 2023 纪念医学博士罗伯特-克罗普 1931 年 11 月 17 日 - 2023 年 9 月 10 日
IF 1.2 Q4 RESPIRATORY SYSTEM Pub Date : 2023-12-01 DOI: 10.1055/a-2210-0362
{"title":"In Gedenken an Dr. med. Robert Kropp 17. November 1931 – 10. September 2023","authors":"","doi":"10.1055/a-2210-0362","DOIUrl":"https://doi.org/10.1055/a-2210-0362","url":null,"abstract":"","PeriodicalId":20197,"journal":{"name":"Pneumologie","volume":"128 ","pages":""},"PeriodicalIF":1.2,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139023732","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Pneumologie
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1